Type 2 diabetes and bone

Journal of Bone and Mineral Research

Volumn 27, Issue 11, 2012, Pages 2231-2237

  Leslie, William D ^a   Rubin, Mishaela R ^b   Schwartz, Ann V ^c   Kanis, John A ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

BONE MINERAL DENSITY; DIABETES; FRACTURE PREDICTION; FRAX; OSTEOPOROSIS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; GLUCOCORTICOID; HEMOGLOBIN A1C; PENTOSIDINE; RALOXIFENE;

ALCOHOL CONSUMPTION; BODY MASS; BONE DENSITY; BONE MATRIX; BONE TURNOVER; CLINICAL PRACTICE; CROSS LINKING; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FOREARM FRACTURE; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PREDICTIVE VALUE; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY OSTEOPOROSIS; SMOKING; SPINE FRACTURE;

BONE AND BONES; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FRACTURES, BONE; HUMANS; RISK ASSESSMENT;

EID: 84867525583     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1759     Document Type: Review

References (83)

1. van Staa TP, Dennison EM, Leufkens HG, Cooper C., Epidemiology of fractures in England and Wales. Bone. 2004; 29: 517-22. (Pubitemid 33124293)
2. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B., Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int. 2000; 11: 669-74.
3. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL., Perspective. How many women have osteoporosis?. J Bone Miner Res. 1992; 7: 1005-10.
4. Blanchard JF, Ludwig S, Wajda A, Dean H, Anderson K, Kendall O, Depew N., Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care. 1996; 19: 807-11. (Pubitemid 26286983)
5. Wild S, Roglic G, Green A, Sicree R, King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 104753.
6. International Diabetes Federation Diabetes Atlas, 5th ed. 2011. International Diabetes Federation [serial online]. Available from: http://www.diabetesatlas.org/content/diabetes-and-impaired-glucose-tolerance (Last accessed May 28, 2012).
7. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB., Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med. 2005; 165: 1612-7. (Pubitemid 41124155)
8. Janghorbani M, Feskanich D, Willett WC, Hu F., Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study. Diabetes Care. 2006; 29: 1573-8. (Pubitemid 44127583)
9. Janghorbani M, Van Dam RM, Willett WC, Hu FB., Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166: 495-505. (Pubitemid 47283633)
10. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL., Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006; 91: 3404-10. (Pubitemid 44402111)
11. De Liefde I, van der Klift M, De Laet CE, van Daele PL, Hofman A, Pols HA., Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005; 16: 1713-20. (Pubitemid 41790880)
12. Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD., Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res. 2003; 18: 784-90. (Pubitemid 36899328)
13. Melton LJ III, Riggs BL, Leibson CL, Achenbach SJ, Camp JJ, Bouxsein ML, Atkinson EJ, Robb RA, Khosla S., A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab. 2008; 93: 4804-9.
14. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM., Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011; 305: 2184-92.
15. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012; 27: 301-8.
16. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int. 2007; 18: 427-44. (Pubitemid 46354916)
17. Vashishth D., The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep. 2007; 5: 62-6. (Pubitemid 46954743)
18. Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD., Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone. 2006; 38: 300-9. (Pubitemid 43255423)
19. Monnier VM, Kohn RR, Cerami A., Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA. 1984; 81: 583-7. (Pubitemid 14186609)
20. Schwartz AV., Diabetes Mellitus: Does it Affect Bone?. Calcif Tissue Int. 2003; 73: 515-9. (Pubitemid 37517795)
21. Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D., Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. 2009; 20: 887-94.
22. Viguet-Carrin S, Garnero P, Delmas PD., The role of collagen in bone strength. Osteoporos Int. 2006; 17: 319-36.
23. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC., Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94: 2380-6.
24. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T., Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2008; 93: 1013-9. (Pubitemid 351398587)
25. Saito M, Fujii K, Soshi S, Tanaka T., Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int. 2006; 17: 986-95. (Pubitemid 43864852)
26. Saito M, Fujii K, Marumo K., Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int. 2006; 79: 160-8. (Pubitemid 44440444)
27. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxsein ML., Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone. 2006; 39: 1073-9. (Pubitemid 44528385)
28. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K., Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res. 2005; 20: 1647-58. (Pubitemid 41243553)
29. Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P., Pentosidine effects on human osteoblasts in vitro. Ann NY Acad Sci. 2008; 1126: 166-72. (Pubitemid 351589306)
30. McCarthy AD, Uemura T, Etcheverry SB, Cortizo AM., Advanced glycation end products interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol. 2004; 36: 840-8. (Pubitemid 38299399)
31. Dobnig H, Piswanger-Solkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A., Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab. 2006; 91: 3355-63. (Pubitemid 44402104)
32. Gerdhem P, Isaksson A, Akesson K, Obrant KJ., Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005; 16: 1506-12. (Pubitemid 41790853)
33. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T., Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94: 45-9.
34. Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S, Matsumoto T., Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab. 1997; 82: 2915-20. (Pubitemid 27385648)
35. Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR., Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2012; 23: 635-41.
36. Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T., Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2012; 97: 1277-84.
37. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM., Bone loss and bone turnover in diabetes. Diabetes. 1995; 44: 775-82.
38. Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabro A, Cataldo D, Stolakis K, Dotta F, Nuti R., Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012; 97: 1737-44.
39. Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV, Cauley JA, Zmuda JM, Hoffman AR, Ensrud KE., Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res. 2010; 25: 285-91.
40. Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, Link TM., High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 95: 5045-55.
41. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB., Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res. 2004; 19: 1084-91. (Pubitemid 41110559)
42. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T., Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res. 2009; 24: 702-9.
43. Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E., Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010; 375: 1729-36.
44. Holzer G, von SG, Holzer LA, Pichl W., Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009; 24: 468-74.
45. Seeman E., Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Bone. 2007; 41: 308-17. (Pubitemid 47199158)
46. Cortes-Sancho R, Perez-Castrillon JL, Martin-Escudero JC, Iglesias S, Alvarez-Manzanares P, Ramos R., Type 2 diabetes mellitus as a risk factor for hip fracture. J Am Geriatr Soc. 2004; 52: 1778-9.
47. Leslie WD, Lix LM, Prior HJ, Derksen S, Metge C, O'Neil J., Biphasic fracture risk in diabetes: A population-based study. Bone. 2007; 40: 1595-601. (Pubitemid 46756425)
48. Melton LJ III, Leibson CL, Achenbach SJ, Therneau TM, Khosla S., Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008; 23: 1334-42. (Pubitemid 352040189)
49. Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F., Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012; 27: 319-32.
50. Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K., Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int. 2005; 16: 907-13. (Pubitemid 41127099)
51. Shan PF, Wu XP, Zhang H, Cao XZ, Yuan LQ, Liao EY., Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest. 2011; 34: 190-6.
52. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T., Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif Tissue Int. 2007; 80: 353-8. (Pubitemid 46956763)
53. Zhou Y, Li Y, Zhang D, Wang J, Yang H., Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract. 2010; 90: 261-9.
54. Agrawal Y, Carey JP, Della Santina CC, Schubert MC, Minor LB., Diabetes, vestibular dysfunction, and falls: analyses from the National Health and Nutrition Examination Survey. Otol Neurotol. 2010; 31: 1445-50.
55. Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES., Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2009; 20: 715-22.
56. Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, Schreiner PJ, Margolis KL, Cauley JA, Nevitt MC, Black DM, Cummings SR., Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care. 2002; 25: 1749-54. (Pubitemid 41071081)
57. Schwartz AV, Vittinghoff E, Sellmeyer DE, Feingold KR, de Rekeneire N, Strotmeyer ES, Shorr RI, Vinik AI, Odden MC, Park SW, Faulkner KA, Harris TB., Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008; 31: 391-6.
58. Volpato S, Leveille SG, Blaum C, Fried LP, Guralnik JM., Risk factors for falls in older disabled women with diabetes: the women's health and aging study. J Gerontol A Biol Sci Med Sci. 2005; 60: 1539-45. (Pubitemid 43146459)
59. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Newman AB., Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006; 55: 1813-8. (Pubitemid 44324137)
60. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR., Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001; 86: 32-8. (Pubitemid 32109771)
61. Cauley JA, Lui LY, Barnes D, Ensrud KE, Zmuda JM, Hillier TA, Hochberg MC, Schwartz AV, Yaffe K, Cummings SR, Newman AB., Successful skeletal aging: a marker of low fracture risk and longevity. The Study of Osteoporotic Fractures (SOF). J Bone Miner Res. 2009; 24: 134-43.
62. Keegan TH, Schwartz AV, Bauer DC, Sellmeyer DE, Kelsey JL., Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. Diabetes Care. 2004; 27: 1547-53. (Pubitemid 38857424)
63. Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB., Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005; 20: 596-603. (Pubitemid 40393067)
64. Strotmeyer ES, Boudreau RM, Marshall LM, Schwartz AV, Bauer DC, Barrett-Connor E, Orwoll E, Cauley J., Higher Bone Mineral Density Loss in Older Men with Diabetes: The Osteoporotic Fractures in Men Study. J Bone Miner Res. 2008; 23 (Suppl 1): S59.
65. Seeman E., Periosteal bone formation - a neglected determinant of bone strength. N Engl J Med. 2003; 349: 320-3. (Pubitemid 36886235)
66. Fraser LA, Pritchard J, Ioannidis G, Giangegorio LM, Adachi JD, Papaioannou A, Leslie WD., Clinical risk factors for fracture in diabetes: a matched cohort analysis. J Clin Densitom. 2011; 14: 416-21.
67. Loke YK, Singh S, Furberg CD., Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ. 2009; 180: 32-9.
68. Nicodemus KK, Folsom AR., Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24: 1192-7. (Pubitemid 33716397)
69. Lipscombe LL, Jamal SA, Booth GL, Hawker GA., The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care. 2007; 30: 835-41. (Pubitemid 46556575)
70. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ., Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care. 2001; 24: 1198-203. (Pubitemid 33716398)
71. Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, O'Connor PJ, Force RW, Bauer DC., Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial. Diabetes Care. 2012; 35: 1525-31.
72. Kanis JA., on behalf of the World Health Organization Scientific Group. 2008. Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre for metabolic Bone Disease, University of Sheffield, UK. Available from: http://www.shef.ac.uk/FRAX. URL: www.nof.org/professionals/WHO-Osteoporosis-Summary.pdf (Last accessed May 28, 2012)
73. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E., FRAX and its applications to clinical practice. Bone. 2009; 44: 734-43.
74. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ III, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033-46. (Pubitemid 47020000)
75. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj FG, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV., Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011; 22: 2395-411.
76. Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD., FRAX((R)) with and without bone mineral density. Calcif Tissue Int. 2012; 90: 1-13.
77. Vestergaard P, Rejnmark L, Mosekilde L., Are antiresorptive drugs effective against fractures in patients with diabetes?. Calcif Tissue Int. 2011; 88: 209-14.
78. Kanis JA, Oden A, Johansson H, McCloskey E., Pitfalls in the external validation of FRAX. Osteoporos Int. 2012; 23: 423-31.
79. Hippisley-Cox J, Coupland C., Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009; 339: b4229.
80. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV, Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV., Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int. 2008; 19: 1431-44.
81. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A., Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005; 16: 155-62. (Pubitemid 40193202)
82. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int. 2011; 22: 839-47.
83. Kanis JA, Johansson H, Oden A, McCloskey EV., Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011; 22: 809-16.